Phemex Astral Trading League (PATL) Goes Live, Building a Sustainable Seasonal Trading Progression System
APIA, Samoa, Feb. 12, 2026 /PRNewswire/ -- Phemex, a user-first crypto exchange,…
Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)
Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met…
ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy
VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing…
